NCT02452086View on ClinicalTrials.gov

Low Level Laser Therapy and Expression of VEGF, NO, VEGFR-2, HIF-1α in Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

February 28, 2015

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Low Level Laser(Ga-As)

Low level laser therapy(904 nm Wavelength), 90 milliwatt, 2 Joule/centimeter2

PROCEDURE

Placebo

LLLT with zero intensity

Trial Locations (1)

Unknown

Tarbiat Modares University, Tehran

All Listed Sponsors
lead

Tarbiat Modarres University

OTHER

NCT02452086 - Low Level Laser Therapy and Expression of VEGF, NO, VEGFR-2, HIF-1α in Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter